{
    "2018-07-23": [
        [
            {
                "time": "",
                "original_text": "华大的“新衣”：魏则西事件后 细胞存储卷土重来",
                "features": {
                    "keywords": [
                        "魏则西事件",
                        "细胞存储",
                        "华大"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因一周宣布三度增持：实际控制人汪建等至少增持1.5亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "增持",
                        "实际控制人",
                        "汪建"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "实际控制人等宣布增持不低于1.5亿元 华大基因一周内增持“三连击”",
                "features": {
                    "keywords": [
                        "华大基因",
                        "实际控制人",
                        "增持",
                        "三连击"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "公告精选：海利生物称未生产人用疫苗产品 华大基因实际控制人等拟增持",
                "features": {
                    "keywords": [
                        "华大基因",
                        "实际控制人",
                        "增持",
                        "海利生物",
                        "人用疫苗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：实际控制人、部分董事及控股股东核心管理团队拟增持不低于1.5亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "实际控制人",
                        "董事",
                        "控股股东",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：董事长等拟增持不低于1.5亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "董事长",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医药短暂调整 后市有望再度走强",
                "features": {
                    "keywords": [
                        "医药行业",
                        "调整",
                        "后市",
                        "走强"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}